Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Bring back dignity to our schoolgirls

2015-03-10

A Kovsie student initiative is currently crying out to the community at large to help in realising a dream of helping school learners who come from poor families to gain confidence in their school work and social lives generally.

This initiative by Nkanyezi Talk @UFS aims to do this through the provision of sanitary towels to such learners at the onset of puberty.

“Through research, we have established that some learners face numerous challenges during this stage, with some using socks as a substitute for sanitary towels while others opt for newspapers. This raises a lot of health and psychological concerns,” says project coordinator Bongani Zwane.

According to research conducted by UNICEF in 2013, one in ten girls who cannot afford sanitary towels will miss a week of schooling during the cycle of their period. This is because they fear being ridiculed by other learners, and because their dignity as girls is not being respected. This absence from school also happens because they do not understand what is happening to their bodies.

“What should be a celebration of womanhood becomes a time of shame and embarrassment with dire consequences for the girls’ education as well as their future,” Zwane adds.

“We therefore appeal to everyone to help us realise this dream of making sure that we reduce the number of schoolgirls who do not attend school during their menstruation periods, and restore their dignity by donating sanitary towels.

“Overall, we have already collected more than 1000 packs of sanitary towels. The office of Cornelia Faasen, our acting dean of Student Affairs, has also endorsed the campaign and already donated 600 packs of sanitary towels,” says Zwane.

“We have set ourselves the goal of collecting and donating 10 000 (ten thousand) sanitary towels in total.”

Methods of Donating

Nkanyezi Talk @UFS welcomes any physical donations of sanitary towels and financial donations through their UFS entity number 1/466/08119 only.

For more information on how and where to donate, please contact project coordinator Bongani Zwane at 079 237 5089 or email him to bzwane@workmail.co.za.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept